Sign in
4

Changes in Ownership

CG Oncology, Inc. Filed Acc 0002007101-26-000002

Chief Executive Officer acquired 102,871 shares (option exercise)

  • Chief Executive Officer gave up 2,871 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Kuan Arthur · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-04 Exercise or conversion : show line 1 in the form +102,871 $1.72 $176,938 139,022 D
2026-03-04 Shares withheld for taxes : show line 2 in the form −2,871 $61.61 $176,882 136,151 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-04 Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) −102,871 64,612 D
Loading xslF345X05/form4-03062026_100310.xml…